AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
This Quarter Return
-7.11%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$86.9M
AUM Growth
+$86.9M
Cap. Flow
-$41.8M
Cap. Flow %
-48.05%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
3
Reduced
1
Closed
1

Top Buys

1
AMWL icon
American Well
AMWL
$9.55M
2
AKBA icon
Akebia Therapeutics
AKBA
$6.02M
3
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$4.31M

Top Sells

1
RNTX
Rein Therapeutics, Inc. Common Stock
RNTX
$37.4M
2
GBT
Global Blood Therapeutics, Inc.
GBT
$24.3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AMWL icon
1
American Well
AMWL
$111M
$29.6M 34.1%
10,475,717
+3,374,944
+48% +$9.55M
ANNX icon
2
Annexon
ANNX
$226M
$22.8M 26.22%
4,408,966
– –
WHWK
3
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
$20.9M 24.07%
1,630,830
+336,045
+26% +$4.31M
AKBA icon
4
Akebia Therapeutics
AKBA
$833M
$8.71M 10.02%
15,090,119
+10,437,558
+224% +$6.02M
ASMB icon
5
Assembly Biosciences
ASMB
$190M
$2.9M 3.33%
2,227,500
– –
RNTX
6
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
$1.97M 2.26%
830,466
-15,778,983
-95% -$37.4M
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-356,270
Closed -$24.3M